NCT02015715 A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants Status COMPLETED Phase PHASE1
NCT02015676 A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02013830 A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer Status COMPLETED Phase PHASE2
NCT02013817 CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy Status COMPLETED Phase PHASE2
NCT02013765 A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer Status TERMINATED Phase PHASE2
NCT02013219 A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT02013206 A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy Status COMPLETED Phase PHASE2
NCT02011334 A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs. Status COMPLETED Phase PHASE3
NCT02010216 A Study of RoActemra/Actemra (Tocilizumab) in Adult Patients With Rheumatoid Arthritis (SVOBODA Programme) Status COMPLETED Phase PHASE4
NCT02008266 Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02008227 A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy Status COMPLETED Phase PHASE3
NCT02006706 A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy Status COMPLETED Phase PHASE3
NCT02006667 A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer Status COMPLETED Phase PHASE2
NCT02005562 OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. Status COMPLETED Phase PHASE3
NCT02005549 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer Status COMPLETED Phase PHASE2
NCT02005484 A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression Status TERMINATED Phase PHASE2
NCT02005471 A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE3
NCT02004106 A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02004093 A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02001987 A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy Status COMPLETED Phase PHASE3